HKU Professor Max Shen elected as International Member of the Chinese Academy of Engineering
Grant and Award Announcement
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 22-Dec-2025 10:11 ET (22-Dec-2025 15:11 GMT/UTC)
A global collaboration including Sunwoda, Chery, Nobel laureate M. Stanley Whittingham, Semitronix, the University of Delaware, and Advance Power, has proposed the "Integrated Battery Large Model," the first AI-driven paradigm covering the entire lithium-ion battery lifecycle. Published in National Science Open, the work outlines a new paradigm for intelligent battery design, manufacturing optimization, defect diagnosis, and lifecycle management through multi-modal AI and simulation synergy.
Artificial intelligence is reshaping brain modeling. This review introduces a unified framework where AI functions as a surrogate brain by integrating dynamical modeling, inverse problem solving, and model evaluation. Trained on neural data, surrogate brains can accurately predict large-scale brain activity and support system analysis, virtual experiments, and model-guided neurostimulation.
EMBARGOED: A new study to be presented Dec. 6 at the 2025 American Society of Hematology (ASH) meeting reveals that even subtle disruptions in genome architecture can predispose individuals to lymphoma. This finding offers a new perspective on understanding and eventually treating blood cancers.
Interactions among viruses can help them succeed inside their hosts or impart vulnerabilities that make them easier to treat. Scientists are learning the ways viruses mingle inside the cells they infect, as well as the consequences of their socializing. Although it is debatable whether viruses are living things, they do compete, cooperate and share genome materials that can sometimes alter their responses to antiviral drugs, result in new variants or play a role in virus evolution. A paper today in Nature Ecology & Evolution by UW Medicine scientists looks at the evolution of poliovirus resistance to a promising experimental antiviral drug, pocapavir. While it seemed counterintuitive, the researchers demonstrated that lowering the potency of pocapavir could improve the situation by enhancing the survival of enough susceptible viruses to continue sensitizing the resistant ones.